{"id":"W2210617513","doi":"10.1155/2007/161652","title":"Treatment Persistence and Compliance with Medications for Chronic Obstructive Pulmonary Disease","year":2007,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); Boehringer Ingelheim (Canada)","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Salmeterol; Ipratropium bromide; Ipratropium; Formoterol; Budesonide/formoterol; COPD; Tiotropium bromide; Asthma; Discontinuation; Salbutamol; Budesonide; Persistence (discontinuity); Internal medicine; Fluticasone; Inhaler; Bronchodilator","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00148305,0.0001724959,0.000379275,0.000942048,0.000619371,0.0006987998,0.0005868803,0.0004635792,0.002072104],"category_scores_gemma":[0.008797061,0.0001939729,0.0005714581,0.001768418,0.0003456206,0.0004906027,0.0004691039,0.0006662069,0.0001687799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00135577,"about_ca_system_score_gemma":0.001363951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04316562,"about_ca_topic_score_gemma":0.07837395,"domain_scores_codex":[0.9978326,0.0003144342,0.0003525285,0.0002302116,0.001035369,0.0002348345],"domain_scores_gemma":[0.9861255,0.001921097,0.009635597,0.0003477635,0.001036087,0.0009338776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002683554,0.00001488132,0.9987944,0.000009185476,0.00003699181,0.0000134124,0.00003073047,0.00001703826,0.00002986096,0.000003389149,0.00005166178,0.0009715078],"study_design_scores_gemma":[0.000002838847,0.00002477613,0.9996637,0.000007083428,0.0000105505,0.00007976567,0.00002730104,0.00007637076,0.0000146073,0.000003925357,0.0000878092,0.000001266752],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963849,0.0007889738,0.00008905134,0.0002169464,0.000006519974,0.00002041186,0.001642701,0.000007550467,0.0008429334],"genre_scores_gemma":[0.9984227,0.0001750873,0.00008792447,0.00003906014,0.00001349046,0.00001240321,0.001080109,0.000001742858,0.0001674151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04316562,"threshold_uncertainty_score":0.08582872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04851666951544207,"score_gpt":0.3109283108508119,"score_spread":0.2624116413353698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}